Jun 19, 2018Retail and Specialty Pharmacy for sale in New York.

The pharmacy has been in business for nearly 8 years. They specialize in dermatology, gastroenterology, infectious disease, and rheumatology.

The pharmacy’s payers include private insurance (70%), Medicare (25%), Medicaid (4%), and cash (1%). Gross revenues were $64 Million in 2017 with an annual script count of 58,500. In 2018, they expect to decline to $42 Million in gross revenue, which is largely due to the lower cost of Hep C drugs. However, their script count is only slightly down, with a projection of 57,000 for the year.

The asking price for this opportunity is $10 Million, which is based on the revenue generated and high volume of scripts.

Sign up today to learn more about this deal and others like it.

By clicking "Sign Up Now - It's Free" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.